Tweenvest Stocks

Aclarion, Inc. (NasdaqCM: ACON)

Health Care · Health Care Technology · US

$2.45

-9.78% today · -62.9% 1Y

Aclarion, Inc. (NasdaqCM: ACON) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $7.81M and employs 11 people.

Over the last twelve months the share price has lost 62.9%, trading between 1.95 and 12.03.

Tweenvest scores Aclarion, Inc. across four factors: quality 26/100, value 47/100, growth 98/100. Its strongest factor is growth.

ACON price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$7.81M
Revenue (TTM)
$83.77K
P/E
EPS
-6.22
Dividend yield
Beta (5Y)
1.22
52-week high
$12.03
52-week low
$1.95
Avg volume (3M)
Shares outstanding
2.88M
Employees
11
Next earnings

About Aclarion, Inc.

Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc.

ISIN
US6551874091
Founded
2008
Listed since
Apr 22, 2022
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
Veeva Systems Inc.NYSE: VEEV$40.09B$244.76-0.82%
Pro Medicus LimitedASX: PME$14.25BAU$190.60-1.46%
M3, Inc.TSE: 2413$7.33B¥1,750.00+1.77%
Sectra AB (publ)OM: SECT B$5.62BSkr276.20+0.15%
Waystar Holding Corp.NasdaqGS: WAY$4.64B$24.17-0.17%
Doximity, Inc.NYSE: DOCS$4.41B$24.90+0.65%
HeartFlow, Inc.NasdaqGS: HTFL$4.34B$49.76-0.26%
Inventurus Knowledge Solutions LimitedNSEI: IKS$3.30BRs1,840.00+6.43%

Browse every Health Care Technology company →

Figures last refreshed Aug 18, 2026.